Christophe Willekens

6.5k total citations
50 papers, 946 citations indexed

About

Christophe Willekens is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, Christophe Willekens has authored 50 papers receiving a total of 946 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Hematology, 17 papers in Genetics and 14 papers in Molecular Biology. Recurrent topics in Christophe Willekens's work include Acute Myeloid Leukemia Research (22 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (9 papers) and Chronic Lymphocytic Leukemia Research (6 papers). Christophe Willekens is often cited by papers focused on Acute Myeloid Leukemia Research (22 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (9 papers) and Chronic Lymphocytic Leukemia Research (6 papers). Christophe Willekens collaborates with scholars based in France, United States and United Kingdom. Christophe Willekens's co-authors include Stéphane de Botton, Johanna Mondésir, Mehdi Touat, Claude Preudhomme, Aline Renneville, Romain Guièze, Éric Solary, Hervé Dombret, Éric Jourdan and Nicolas Boissel and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Christophe Willekens

47 papers receiving 941 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christophe Willekens France 18 453 375 255 186 162 50 946
Xiujin Ye China 16 526 1.2× 326 0.9× 140 0.5× 253 1.4× 236 1.5× 94 984
C. Michel Zwaan Netherlands 18 313 0.7× 293 0.8× 147 0.6× 280 1.5× 117 0.7× 74 943
Angela Hamblin United Kingdom 11 207 0.5× 288 0.8× 202 0.8× 179 1.0× 157 1.0× 32 708
Bhavana Bhatnagar United States 17 438 1.0× 390 1.0× 124 0.5× 299 1.6× 93 0.6× 79 877
Annie Im United States 13 403 0.9× 242 0.6× 139 0.5× 301 1.6× 231 1.4× 64 851
Abhishek Maiti United States 19 777 1.7× 411 1.1× 283 1.1× 248 1.3× 97 0.6× 131 1.1k
S. Faderl United States 16 882 1.9× 417 1.1× 393 1.5× 240 1.3× 87 0.5× 24 1.2k
Valentina Gianfelici Italy 15 312 0.7× 243 0.6× 133 0.5× 168 0.9× 113 0.7× 29 736
Shira Dinner United States 16 380 0.8× 313 0.8× 157 0.6× 218 1.2× 86 0.5× 67 727
Rita Assi United States 13 388 0.9× 230 0.6× 137 0.5× 237 1.3× 70 0.4× 49 824

Countries citing papers authored by Christophe Willekens

Since Specialization
Citations

This map shows the geographic impact of Christophe Willekens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christophe Willekens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christophe Willekens more than expected).

Fields of papers citing papers by Christophe Willekens

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christophe Willekens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christophe Willekens. The network helps show where Christophe Willekens may publish in the future.

Co-authorship network of co-authors of Christophe Willekens

This figure shows the co-authorship network connecting the top 25 collaborators of Christophe Willekens. A scholar is included among the top collaborators of Christophe Willekens based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christophe Willekens. Christophe Willekens is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sonigo, Charlotte, Florence Eustache, Christophe Willekens, et al.. (2025). Hematologic cancers in women: from fertility preservation to post-cancer fertility outcomes. Human Reproduction. 40(7). 1315–1324. 1 indexed citations
2.
Willekens, Christophe, et al.. (2024). RAS mutations in myeloid malignancies: revisiting old questions with novel insights and therapeutic perspectives. Blood Cancer Journal. 14(1). 72–72. 21 indexed citations
3.
Pagès, Arnaud, Rudy Birsen, Adrien Contejean, et al.. (2024). Venetoclax–proteasome inhibitor–dexamethasone for unfit patients with blastic plasmacytoid dendritic cell neoplasm. Blood Advances. 9(4). 793–796. 2 indexed citations
4.
Bazinet, Alexandre, Courtney D. DiNardo, Álex Bataller, et al.. (2024). A retrospective comparison of abbreviated course “7+7” vs standard hypomethylating agent plus venetoclax doublets in older/unfit patients with newly diagnosed acute myeloid leukemia.. Journal of Clinical Oncology. 42(16_suppl). 6507–6507. 7 indexed citations
5.
6.
Baldini, Capucine, Stéphanie Foulon, Arnaud Bayle, et al.. (2020). Outcome of older cancer patients infected with Covid19 at Gustave Roussy Cancer Center. Clinical Cancer Research. 26(18). 2 indexed citations
7.
Salamero, Olga, Pau Montesinos, Christophe Willekens, et al.. (2020). First-in-Human Phase I Study of Iadademstat (ORY-1001): A First-in-Class Lysine-Specific Histone Demethylase 1A Inhibitor, in Relapsed or Refractory Acute Myeloid Leukemia. Journal of Clinical Oncology. 38(36). 4260–4273. 73 indexed citations
8.
Heiblig, Maël, Christophe Willekens, Jean‐Baptiste Micol, et al.. (2020). Enasidenib for the treatment of relapsed or refractory acute myeloid leukemia with an isocitrate dehydrogenase 2 mutation. Expert Review of Precision Medicine and Drug Development. 5(6). 421–428. 3 indexed citations
9.
Baldini, Capucine, Stéphanie Foulon, Arnaud Bayle, et al.. (2020). 1688P Outcome of older cancer patients infected with COVID-19 at Gustave Roussy Cancer Center. Annals of Oncology. 31. S998–S998. 1 indexed citations
10.
Saleh, Khalil, Florence Pasquier, Cyril Quivoron, et al.. (2019). Clonal Hematopoiesis in the Molecular Landscape of Therapy-Related Myeloid Neoplasms in Patients Previously Treated for Gynecologic and Breast Cancers. Blood. 134(Supplement_1). 3722–3722. 1 indexed citations
11.
Michot, Jean‐Marie, Maxime Annereau, Alina Danu, et al.. (2019). High‐dose cyclophosphamide for hard‐to‐treat patients with relapsed or refractory B‐cell non‐Hodgkin's lymphoma, a phase II result. European Journal Of Haematology. 104(4). 281–290. 6 indexed citations
12.
Selimoglu‐Buet, Dorothée, Julie Rivière, Hussein Ghamlouch, et al.. (2018). A miR-150/TET3 pathway regulates the generation of mouse and human non-classical monocyte subset. Nature Communications. 9(1). 5455–5455. 28 indexed citations
13.
Willekens, Christophe, Véronique Saada, Sophie Broutin, et al.. (2017). Efficacy of 5-Azacitidine on IDH1/2 Acute Myeloid Leukemia/Myelodysplastic Syndromes and Correlation with 2-Hydroxyglutarate Production. Blood. 130. 1313–1313. 1 indexed citations
14.
15.
Rossignol, Julien, Louis Terriou, Christophe Willekens, et al.. (2015). Radioimmunotherapy (90Y-Ibritumomab Tiuxetan) for Posttransplant Lymphoproliferative Disorders After Prior Exposure to Rituximab. American Journal of Transplantation. 15(7). 1976–1981. 10 indexed citations
16.
17.
18.
Willekens, Christophe, Odile Blanchet, Aline Renneville, et al.. (2015). Prospective long-term minimal residual disease monitoring using RQ-PCR in RUNX1-RUNX1T1-positive acute myeloid leukemia: results of the French CBF-2006 trial. Haematologica. 101(3). 328–335. 87 indexed citations
19.
Patel, Satyananda, M. Wittner, Christophe Willekens, et al.. (2012). CXCR4 inhibitors selectively eliminate CXCR4-expressing human acute myeloid leukemia cells in NOG mouse model. Cell Death and Disease. 3(10). e396–e396. 52 indexed citations
20.
Wémeau, Mathieu, Laurent Pascal, Bénédicte Hivert, et al.. (2011). Prognostic value of PINI index in patients with multiple myeloma. European Journal Of Haematology. 88(4). 306–313. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xiujin Ye Breakdown of academic impact, for papers by C. Michel Zwaan Breakdown of academic impact, for papers by Angela Hamblin Breakdown of academic impact, for papers by Bhavana Bhatnagar Breakdown of academic impact, for papers by Annie Im Breakdown of academic impact, for papers by Abhishek Maiti Breakdown of academic impact, for papers by S. Faderl Breakdown of academic impact, for papers by Valentina Gianfelici Breakdown of academic impact, for papers by Shira Dinner Breakdown of academic impact, for papers by Rita Assi
Rankless by CCL
2026